Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Credit Suisse Upgrades ArcelorMittal to Outperform, Raises Price Target to $42

Credit Suisse analyst Carsten Riek upgrades ArcelorMittal (NYSE:MT) from Neutral to Outperform and raises the price target from $34 to $42.

byBenzinga Newsdesk

October 14, 2021

1 minute read

Credit Suisse analyst Carsten Riek upgrades ArcelorMittal (NYSE:MT) from Neutral to Outperform and raises the price target from $34 to $42.

Cowen & Co. Maintains Outperform on Eli Lilly, Raises Price Target to $300

By vishwanath@benzinga.com

Today, 5:06 AM

Cowen & Co. analyst Steve Scala maintains Eli Lilly (NYSE:LLY) with a Outperform and raises the price target from $250 to $300.

LLY

EMA Approves Additional Sites To Boost Output Capacity For mRNA-Based COVID-19 Vaccines

By Vandana Singh

Today, 5:06 AM

European Medical Agency (EMA) has approved additional manufacturing sites for mRNA-based coronavirus vaccines developed by Pfizer Inc (NYSE:PFE) – BioNTech SE (NASDAQ:BNTX) and Moderna Inc (NASDAQ:MRNA)…

BNTX

30 Stocks Moving in Thursday’s Pre-Market Session

By Lisa Levin

Today, 5:06 AM

Gainers Conifer Holdings, Inc. (NASDAQ: CNFR) shares rose 40.9% to $4.00 in pre-market trading after the company reported better-than-expected Q2 sales.

AEG

News

Chinese Authorities Haven’t Identified Problems With Boeing Plane Involved In Crash

By Benzinga Newsdesk

Today, 5:06 AM

-Wall Street Journal Report

Credit Suisse Upgrades ArcelorMittal to Outperform, Raises Price Target to $42

Related Posts

Cowen & Co. Maintains Outperform on Eli Lilly, Raises Price Target to $300

EMA Approves Additional Sites To Boost Output Capacity For mRNA-Based COVID-19 Vaccines

30 Stocks Moving in Thursday’s Pre-Market Session

Chinese Authorities Haven’t Identified Problems With Boeing Plane Involved In Crash